{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:02:39Z","timestamp":1792724559009,"version":"4.5.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1602\/neurorx.2.3.495","type":"journal-article","created":{"date-parts":[[2005,6,13]],"date-time":"2005-06-13T18:23:36Z","timestamp":1118687016000},"page":"495-503","source":"Crossref","is-referenced-by-count":143,"title":["Genetic mouse models of parkinsonism: Strengths and limitations"],"prefix":"10.1007","volume":"2","author":[{"given":"Sheila M.","family":"Fleming","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Olivier","family":"Fernagut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Fran\u00e7oise","family":"Chesselet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"20300495_CR1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/brain\/awh322","volume":"128","author":"K Stiasny-Kolster","year":"2005","unstructured":"Stiasny-Kolster K, Doerr Y, Moller JC, Hoffken H, Behr TM, Oertel WH, Mayer G. Combination of \u201cidiopathic\u201d REM sleep behaviour disorder and olfactory dysfunction as possible indicator for \u03b1-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 128: 126\u2013137, 2005.","journal-title":"Brain"},{"key":"20300495_CR2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/ana.20160","volume":"56","author":"MM Ponsen","year":"2004","unstructured":"Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters E, Berendse HW. Idiopathic hyposmia as a preclinical sign of Parkinson\u2019s disease. Ann Neurol 56: 173\u2013181, 2004.","journal-title":"Ann Neurol"},{"issue":"Suppl 3","key":"20300495_CR3","first-page":"III40","volume":"249","author":"G Becker","year":"2002","unstructured":"Becker G, Muller A, Braune S, Buttner T, Benecke R, Greulich W, Klein W, Mark G, Rieke J, Thumler R. Early diagnosis of Parkinson\u2019s disease. J Neurol 249 [Suppl 3]: III40-III48, 2002.","journal-title":"J Neurol"},{"key":"20300495_CR4","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1077209","volume":"299","author":"V Bonifati","year":"2003","unstructured":"Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, Dekker MC, Squitieri F, Ibanez P, Joosse M, van Dongen JW, Vanacore N, van Swieten JC, Brice A, Meco G, van Duijn CM, Oostra BA, Heutink P. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299: 256\u2013259, 2003.","journal-title":"Science"},{"key":"20300495_CR5","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"T Kitada","year":"1998","unstructured":"Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392: 605\u2013608, 1998.","journal-title":"Nature"},{"key":"20300495_CR6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kruger","year":"1998","unstructured":"Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, Riess O. Ala30Pro mutation in the gene encoding \u03b1-synuclein in Parkinson\u2019s disease. Nat Genet 18: 106\u2013108, 1998.","journal-title":"Nat Genet"},{"key":"20300495_CR7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s004390050845","volume":"103","author":"E Leroy","year":"1998","unstructured":"Leroy E, Anastasopoulos D, Konitsiotis S, Lavedan C, Polymeropoulos MH. Deletions in the Parkin gene and genetic heterogeneity in a Greek family with early onset Parkinson\u2019s disease. Hum Genet 103: 424\u2013427, 1998.","journal-title":"Hum Genet"},{"key":"20300495_CR8","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL. Mutation in the \u03b1-synuclein gene identified in families with Parkinson\u2019s disease. Science 276: 2045\u20132047, 1997.","journal-title":"Science"},{"key":"20300495_CR9","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Faner M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K. \u03b1-synuclein locus triplication causes Parkinson\u2019s disease. Science 302: 841, 2003.","journal-title":"Science"},{"key":"20300495_CR10","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1097\/00001756-200007140-00004","volume":"11","author":"P Wintermeyer","year":"2000","unstructured":"Wintermeyer P, Kruger R, Kuhn W, Muller T, Woitalla D, Berg D, Becker G, Leroy E, Polymeropoulos M, Berger K, Przuntek H, Schols L, Epplen JT, Riess O. Mutation analysis and association studies of the UCHL1 gene in German Parkinson\u2019s disease patients. Neuroreport 11: 2079\u20132082, 2000.","journal-title":"Neuroreport"},{"key":"20300495_CR11","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","volume":"304","author":"EM Valente","year":"2004","unstructured":"Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Al-banese A, Nussbaum R, Gonzalez-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, Wood NW. Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1. Science 304: 1158\u20131160, 2004.","journal-title":"Science"},{"key":"20300495_CR12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","volume":"44","author":"C Paisan-Ruiz","year":"2004","unstructured":"Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, van der Brug M, de Munain AL, Aparicio S, Gil AM, Khan N, Johnson J, Martinez JR, Nicholl D, Carrera IM, Pena AS, de Silva R, Lees A, Marti-Masso JF, Perez-Tur J, Wood NW, Singleton AB. Cloning of the gene containing mutations that cause PARK8-linked Parkinson\u2019s disease. Neuron 44: 595\u2013600, 2004.","journal-title":"Neuron"},{"key":"20300495_CR13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1086\/380647","volume":"74","author":"A Zimprich","year":"2004","unstructured":"Zimprich A, Muller-Myhsok B, Farrer M, Leitner P, Sharma M, Hulihan M, Lockhart P, Strongosky A, Kachergus J, Calne DB, Stoessl J, Uitti RJ, Pfeiffer RF, Trenkwalder C, Homann N, Ott E, Wenzel K, Asmus F, Hardy J, Wszolek Z, Gasser T. The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval. Am J Hum Genet 74: 11\u201319, 2004.","journal-title":"Am J Hum Genet"},{"key":"20300495_CR14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1749-6632.2000.tb06900.x","volume":"920","author":"MG Spillantini","year":"2000","unstructured":"Spillantini MG, Goedert M. The \u03b1-synucleinopathies: Parkinson\u2019s disease, dementia with Lewy bodies, and multiple system atrophy. Ann NY Acad Sci 920: 16\u201327, 2000.","journal-title":"Ann NY Acad Sci"},{"key":"20300495_CR15","doi-asserted-by":"crossref","first-page":"8797","DOI":"10.1523\/JNEUROSCI.22-20-08797.2002","volume":"22","author":"DE Cabin","year":"2002","unstructured":"Cabin DE, Shimazu K, Murphy D, Cole NB, Gottschalk W, McIlwain KL, Orrison B, Chen A, Ellis CE, Paylor R, Lu B, Nussbaum RL. Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking \u03b1-synuclein. J Neurosci 22: 8797\u20138807, 2002.","journal-title":"J Neurosci"},{"key":"20300495_CR16","doi-asserted-by":"crossref","first-page":"11165","DOI":"10.1523\/JNEUROSCI.2559-04.2004","volume":"24","author":"L Yavich","year":"2004","unstructured":"Yavich L, Tanila H, Vepsalainen S, Jakala P. Role of \u03b1-synuclein in presynaptic dopamine recruitment. J Neurosci 24: 11165\u201311170, 2004.","journal-title":"J Neurosci"},{"key":"20300495_CR17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atares B, Llorens V, Gomez Tortosa E, del Ser T, Munoz DG, de Yebenes JG. The new mutation, E46K, of \u03b1-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55: 164\u2013173, 2004.","journal-title":"Ann Neurol"},{"key":"20300495_CR18","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0140-6736(04)17104-3","volume":"364","author":"P Ibanez","year":"2004","unstructured":"Ibanez P, Bonnet AM, Debarges B, Lohmann E, Tison F, Pollak P, Agid Y, Durr A, Brice A. Causal relation between \u03b1-synuclein gene duplication and familial Parkinson\u2019s disease. Lancet 364: 1169\u20131171, 2004.","journal-title":"Lancet"},{"key":"20300495_CR19","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","volume":"364","author":"MC Chartier-Harlin","year":"2004","unstructured":"Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, Levecque C, Larvor L, Andrieux J, Hulihan M, Waucquier N, Defebvre L, Amouyel P, Farrer M, Destee A. \u03b1-synuclein locus duplication as a cause of familial Parkinson\u2019s disease. Lancet 364: 1167\u20131169, 2004.","journal-title":"Lancet"},{"key":"20300495_CR20","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1093\/hmg\/10.17.1847","volume":"10","author":"M Farrer","year":"2001","unstructured":"Farrer M, Maraganore DM, Lockhart P, Singleton A, Lesnick TG, de Andrade M, West A, de Silva R, Hardy J, Hernandez D. \u03b1-synuclein gene haplotypes are associated with Parkinson\u2019s disease. Hum Mol Genet 10: 1847\u20131851, 2001.","journal-title":"Hum Mol Genet"},{"key":"20300495_CR21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00702-002-0769-5","volume":"110","author":"C Holzmann","year":"2003","unstructured":"Holzmann C, Kruger R, Saecker AM, Schmitt I, Schols L, Berger K, Riess O. Polymorphisms of the \u03b1-synuclein promoter: expression analyses and association studies in Parkinson\u2019s disease. J Neural Transm 110: 67\u201376, 2003.","journal-title":"J Neural Transm"},{"key":"20300495_CR22","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ana.20268","volume":"56","author":"P Pals","year":"2004","unstructured":"Pals P, Lincoln S, Manning J, Heckman M, Skipper L, Hulihan M, Van den Broeck M, De Pooter T, Cras P, Crook J, Van Broeckhoven C, Faner MJ. \u03b1-synuclein promoter confers susceptibility to Parkinson\u2019s disease. Ann Neurol 56: 591\u2013595, 2004.","journal-title":"Ann Neurol"},{"key":"20300495_CR23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","volume":"25","author":"A Abeliovich","year":"2000","unstructured":"Abeliovich A, Schmitz Y, Farinas I, Choi-Lundberg D, Ho WH, Castillo PE, Shinsky N, Verdugo JM, Armanini M, Ryan A, Hynes M, Phillips H, Sulzer D, Rosenthal A. Mice lacking \u03b1-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25: 239\u2013252, 2000.","journal-title":"Neuron"},{"key":"20300495_CR24","doi-asserted-by":"crossref","first-page":"14966","DOI":"10.1073\/pnas.0406283101","volume":"101","author":"S Chandra","year":"2004","unstructured":"Chandra S, Fomai F, Kwon HB, Yazdani U, Atasoy D, Liu X, Hammer RE, Battaglia G, German DC, Castillo PE, Sudhof TC. Double-knockout mice for \u03b1- and \u03b2-synucleins: effect on synaptic functions. Proc Natl Acad Sci USA 101: 14966\u201314971, 2004.","journal-title":"Proc Natl Acad Sci USA"},{"key":"20300495_CR25","doi-asserted-by":"crossref","first-page":"14524","DOI":"10.1073\/pnas.172514599","volume":"99","author":"W Dauer","year":"2002","unstructured":"Dauer W, Kholodilov N, Vila M, Trillat AC, Goodchild R, Larsen KE, Staal R, Tieu K, Schmitz Y, Yuan CA, Rocha M, Jackson-Lewis V, Hersch S, Sulzer D, Przedborski S, Burke R, Hen R. Resistance of \u03b1-synuclein null mice to the parkinsonian neurotoxin MPTP. Proc Natl Acad Sci USA 99: 14524\u201314529, 2002.","journal-title":"Proc Natl Acad Sci USA"},{"key":"20300495_CR26","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0306-4522(03)00036-8","volume":"118","author":"OM Schluter","year":"2003","unstructured":"Schluter OM, Fornai F, Alessandri MG, Takamori S, Geppert M, Jahn R, Sudhof TC. Role of \u03b1-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice. Neuroscience 118: 985\u20131002, 2003.","journal-title":"Neuroscience"},{"key":"20300495_CR27","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.neuro.2004.05.002","volume":"25","author":"RE Drolet","year":"2004","unstructured":"Drolet RE, Behrouz B, Lookingland KJ, Goudreau JL. Mice lacking \u03b1-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration. Neurotoxicology 25: 761\u2013769, 2004.","journal-title":"Neurotoxicology"},{"key":"20300495_CR28","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.1523\/JNEUROSCI.20-17-06365.2000","volume":"20","author":"PJ Kahle","year":"2000","unstructured":"Kahle PJ, Neumann M, Ozmen L, Muller V, Jacobsen H, Schindzielorz A, Okochi M, Leimer U, van Der Putten H, Probst A, Kremmer E, Kretzschmar HA, Haass C. Subcellular localization of wild-type and Parkinson\u2019s disease-associated mutant \u03b1-synuclein in human and transgenic mouse brain. J Neurosci 20: 6365\u20136373, 2000.","journal-title":"J Neurosci"},{"key":"20300495_CR29","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1523\/JNEUROSCI.20-16-06021.2000","volume":"20","author":"H Putten van der","year":"2000","unstructured":"van der Putten H, Wiederhold KH, Probst A, Barbieri S, Mistl C, Danner S, Kauffmann S, Hofele K, Spooren WP, Ruegg MA, Lin S, Caroni P, Sommer B, Tolnay M, Bilbe G. Neuropathology in mice expressing human \u03b1-synuclein. J Neurosci 20: 6021\u20136029, 2000.","journal-title":"J Neurosci"},{"key":"20300495_CR30","doi-asserted-by":"crossref","first-page":"8968","DOI":"10.1073\/pnas.132197599","volume":"99","author":"MK Lee","year":"2002","unstructured":"Lee MK, Stilling W, Xu Y, Xu X, Qui D, Mandir AS, Dawson TM, Copeland NG, Jenkins NA, Price DL. Human \u03b1-synuclein-harboring familial Parkinson\u2019s disease-linked Ala-53 -> Thr mutation causes neurodegenerative disease with \u03b1-synuclein aggregation in transgenic mice. Proc Natl Acad Sci USA 99: 8968\u20138973, 2002.","journal-title":"Proc Natl Acad Sci USA"},{"key":"20300495_CR31","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","volume":"34","author":"BI Giasson","year":"2002","unstructured":"Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM. Neuronal \u03b1-synucleinopathy with severe movement disorder in mice expressing A53T human \u03b1-synuclein. Neuron 34: 521\u2013533, 2002.","journal-title":"Neuron"},{"key":"20300495_CR32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0197-4580(02)00091-X","volume":"24","author":"T Gomez-Isla","year":"2003","unstructured":"Gomez-Isla T, Irizarry MC, Mariash A, Cheung B, Soto O, Schrump S, Sondel J, Kotilinek L, Day J, Schwarzschild MA, Cha JH, Newell K, Miller DW, Ueda K, Young AB, Hyman BT, Ashe KH. Motor dysfunction and gliosis with preserved dopaminergic markers in human \u03b1-synuclein A30P transgenic mice. Neurobiol Aging 24: 245\u2013258, 2003.","journal-title":"Neurobiol Aging"},{"key":"20300495_CR33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/exnr.2002.7882","volume":"175","author":"EK Richfield","year":"2002","unstructured":"Richfield EK, Thiruchelvam MJ, Cory-Slechta DA, Wuertzer C, Gainetdinov RR, Caron MG, Di Monte DA, Federoff HJ. Behavioral and neurochemical effects of wild-type and mutated human \u03b1-synuclein in transgenic mice. Exp Neurol 175: 35\u201348, 2002.","journal-title":"Exp Neurol"},{"key":"20300495_CR34","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jnr.10231","volume":"68","author":"E Rockenstein","year":"2002","unstructured":"Rockenstein E, Mallory M, Hashimoto M, Song D, Shults CW, Lang I, Masliah E. Differential neuropathological alterations in transgenic mice expressing \u03b1-synuclein from the platelet-derived growth factor and Thy-1 promoters. J Neurosci Res 68: 568\u2013578, 2002.","journal-title":"J Neurosci Res"},{"key":"20300495_CR35","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","volume":"287","author":"E Masliah","year":"2000","unstructured":"Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, Mucke L. Dopaminergic loss and inclusion body formation in \u03b1-synuclein mice: implications for neurodegenerative disorders. Science 287: 1265\u20131269, 2000.","journal-title":"Science"},{"key":"20300495_CR36","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1044-7431(03)00198-2","volume":"24","author":"S Gispert","year":"2003","unstructured":"Gispert S, Del Turco D, Garrett L, Chen A, Bernard DJ, Hamm-Clement J, Korf HW, Deller T, Braak H, Auburger G, Nussbaum RL. Transgenic mice expressing mutant A53T human \u03b1-synuclein show neuronal dysfunction in the absence of aggregate formation. Mol Cell Neurosci 24: 419\u2013429, 2003.","journal-title":"Mol Cell Neurosci"},{"key":"20300495_CR37","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.0953-816X.2004.03139.x","volume":"19","author":"MJ Thiruchelvam","year":"2004","unstructured":"Thiruchelvam MJ, Powers JM, Cory-Slechta DA, Richfield EK. Risk factors for dopaminergic neuron loss in human \u03b1-synuclein transgenic mice. Eur J Neurosci 19: 845\u2013854, 2004.","journal-title":"Eur J Neurosci"},{"key":"20300495_CR38","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0014-4886(03)00342-X","volume":"186","author":"DD Song","year":"2004","unstructured":"Song DD, Shults CW, Sisk A, Rockenstein E, Masliah E. Enhanced substantia nigra mitochondrial pathology in human \u03b1-synuclein transgenic mice after treatment with MPTP. Exp Neurol 186: 158\u2013172, 2004.","journal-title":"Exp Neurol"},{"key":"20300495_CR39","doi-asserted-by":"crossref","first-page":"9434","DOI":"10.1523\/JNEUROSCI.3080-04.2004","volume":"24","author":"SM Fleming","year":"2004","unstructured":"Fleming SM, Salcedo J, Femagut PO, Rockenstein E, Masliah E, Levine MS, Chesselet MF. Early and progressive sensorimotor anomalies in mice overexpressing wild-type human \u03b1-synuclein. J Neurosci 24: 9434\u20139440, 2004.","journal-title":"J Neurosci"},{"key":"20300495_CR40","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ana.410400609","volume":"40","author":"KA Frey","year":"1996","unstructured":"Frey KA, Koeppe RA, Kilbourn MR, Vander Borght TM, Albin RL, Gilman S, Kuhl DE. Presynaptic monoaminergic vesicles in Parkinson\u2019s disease and normal aging. Ann Neurol 40: 873\u2013884, 1996.","journal-title":"Ann Neurol"},{"key":"20300495_CR41","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/jnnp.67.6.737","volume":"67","author":"JO Rinne","year":"1999","unstructured":"Rinne JO, Ruottinen H, Bergman J, Haaparanta M, Sonninen P, Solin O. Usefulness of a dopamine transporter PET ligand [(18)F]\u03b2-CFT in assessing disability in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 67: 737\u2013741, 1999.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"20300495_CR42","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1056\/NEJM200005253422103","volume":"342","author":"CB Lucking","year":"2000","unstructured":"Lucking CB, Durr A, Bonifati V, Vaughan J, De Michele G, Gasser T, Harhangi BS, Meco G, Denefle P, Wood NW, Agid Y, Brice A. Association between early-onset Parkinson\u2019s disease and mutations in the parkin gene. French Parkinson\u2019s Disease Genetics Study Group. N Engl J Med 342: 1560\u20131567, 2000.","journal-title":"N Engl J Med"},{"key":"20300495_CR43","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/1531-8257(200009)15:5<884::AID-MDS1019>3.0.CO;2-8","volume":"15","author":"S Hayashi","year":"2000","unstructured":"Hayashi S, Wakabayashi K, Ishikawa A, Nagai H, Saito M, Maruyama M, Takahashi T, Ozawa T, Tsuji S, Takahashi H. An autopsy case of autosomal-recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene. Mov Disord 15: 884\u2013888, 2000.","journal-title":"Mov Disord"},{"key":"20300495_CR44","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.51.3.890","volume":"51","author":"H Mori","year":"1998","unstructured":"Mori H, Kondo T, Yokochi M, Matsumine H, Nakagawa-Hattori Y, Miyake T, Suda K, Mizuno Y. Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. Neurology 51: 890\u2013892, 1998.","journal-title":"Neurology"},{"key":"20300495_CR45","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1212\/WNL.44.3_Part_1.437","volume":"44","author":"H Takahashi","year":"1994","unstructured":"Takahashi H, Ohama E, Suzuki S, Horikawa Y, Ishikawa A, Morita T, Tsuji S, Ikuta F. Familial juvenile parkinsonism: clinical and pathologic study in a family. Neurology 44: 437\u2013441, 1994.","journal-title":"Neurology"},{"key":"20300495_CR46","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/ana.1132","volume":"50","author":"M Faner","year":"2001","unstructured":"Faner M, Chan P, Chen R, Tan L, Lincoln S, Hernandez D, Fomo L, Gwinn-Hardy K, Petrucelli L, Hussey J, Singleton A, Tanner C, Hardy J, Langsten JW. Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol 50: 293\u2013300, 2001.","journal-title":"Ann Neurol"},{"key":"20300495_CR47","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0092-8674(01)00407-X","volume":"105","author":"Y Imai","year":"2001","unstructured":"Imai Y, Soda M, Inoue H, Hattori N, Mizuno Y, Takahashi R. An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell 105: 891\u2013902, 2001.","journal-title":"Cell"},{"key":"20300495_CR48","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.1060627","volume":"293","author":"H Shimura","year":"2001","unstructured":"Shimura H, Schlossmacher MG, Hattori N, Frosch MP, Trockenbacher A, Schneider R, Mizuno Y, Kosik KS, Selkoe DJ. Ubiquitination of a new form of \u03b1-synuclein by parkin from human brain: implications for Parkinson\u2019s disease. Science 293: 263\u2013269, 2001.","journal-title":"Science"},{"key":"20300495_CR49","doi-asserted-by":"crossref","first-page":"13354","DOI":"10.1073\/pnas.240347797","volume":"97","author":"Y Zhang","year":"2000","unstructured":"Zhang Y, Gao J, Chung KK, Huang H, Dawson VL, Dawson TM. Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc Natl Acad Sci USA 97: 13354\u201313359, 2000.","journal-title":"Proc Natl Acad Sci USA"},{"key":"20300495_CR50","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nm1001-1144","volume":"7","author":"KK Chung","year":"2001","unstructured":"Chung KK, Zhang Y, Lim KL, Tanaka Y, Huang H, Gao J, Ross CA, Dawson VL, Dawson TM. Parkin ubiquitinates the \u03b1-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat Med 7: 1144\u20131150, 2001.","journal-title":"Nat Med"},{"key":"20300495_CR51","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/hmg\/ddg239","volume":"12","author":"JM Itier","year":"2003","unstructured":"Itier JM, Ibanez P, Mena MA, Abbas N, Cohen-Salmon C, B\u00f6hme GA, Laville M, Pratt J, Corti O, Pradier L, Ret G, Joubert C, Periquet M, Araujo F, Negroni J, Casarejos MJ, Canals S, Solano R, Serrano A, Gallego E, Sanchez M, Denefle P, Benavides J, Tremp G, Rooney TA, Brice A, Garcia de Yebenes J. Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Hum Mol Genet 12: 2277\u20132291, 2003.","journal-title":"Hum Mol Genet"},{"key":"20300495_CR52","doi-asserted-by":"crossref","first-page":"43628","DOI":"10.1074\/jbc.M308947200","volume":"278","author":"MS Goldberg","year":"2003","unstructured":"Goldberg MS, Fleming SM, Palacino JJ, Cepeda C, Lam HA, Bhatnagar A, Meloni EG, Wu N, Ackerson LC, Klapstein GJ, Gajendiran M, Roth BL, Chesselet MF, Maidment NT, Levine MS, Shen J. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem 278: 43628\u201343635, 2003.","journal-title":"J Biol Chem"},{"key":"20300495_CR53","doi-asserted-by":"crossref","first-page":"10744","DOI":"10.1073\/pnas.0401297101","volume":"101","author":"R Coelln Von","year":"2004","unstructured":"Von Coelln R, Thomas B, Savitt JM, Lim KL, Sasaki M, Hess EJ, Dawson VL, Dawson TM. Loss of locus coeruleus neurons and reduced startle in parkin null mice. Proc Natl Acad Sci USA 101: 10744\u201310749, 2004.","journal-title":"Proc Natl Acad Sci USA"},{"key":"20300495_CR54","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1073\/pnas.0409598102","volume":"102","author":"FA Perez","year":"2005","unstructured":"Perez FA, Palmiter RD. Parkin-deficient mice are not a robust model of parkinsonism. Proc Natl Acad Sci USA 102: 2174\u20132179, 2005.","journal-title":"Proc Natl Acad Sci USA"},{"key":"20300495_CR55","doi-asserted-by":"crossref","first-page":"18614","DOI":"10.1074\/jbc.M401135200","volume":"279","author":"JJ Palacino","year":"2004","unstructured":"Palacino JJ, Sagi D, Goldberg MS, Krauss S, Motz C, Wacker M, Klose J, Shen J. Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J Biol Chem 279: 18614\u201318622, 2004.","journal-title":"J Biol Chem"},{"key":"20300495_CR56","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ana.410320510","volume":"32","author":"DC German","year":"1992","unstructured":"German DC, Manaye KF, White CL 3rd, Woodward DJ, McIntire DD, Smith WK, Kalaria RN, Mann DM. Disease-specific patterns of locus coeruleus cell loss. Ann Neurol 32: 667\u2013676, 1992.","journal-title":"Ann Neurol"},{"key":"20300495_CR57","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.144.3616.309","volume":"144","author":"RL Sidman","year":"1964","unstructured":"Sidman RL, Dickie MM, Appel SH. Mutant mice (Quaking and Jimpy) with deficient myelination in the central nervous system. Science 144: 309\u2013311, 1964.","journal-title":"Science"},{"key":"20300495_CR58","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00335-003-2333-5","volume":"15","author":"D Lorenzetti","year":"2004","unstructured":"Lorenzetti D, Antalffy B, Vogel H, Noveroske J, Armstrong D, Justice M. The neurological mutant quaking (viable) is Parkin deficient. Mamm Genome 15: 210\u2013217, 2004.","journal-title":"Mamm Genome"},{"key":"20300495_CR59","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/mds.20000","volume":"19","author":"PJ Lockhart","year":"2004","unstructured":"Lockhart PJ, O\u2019Farrell CA, Faner MJ. It\u2019s a double knock-out! The quaking mouse is a spontaneous deletion of parkin and parkin co-regulated gene (PACRG). Mov Disord 19: 101\u2013104, 2004.","journal-title":"Mov Disord"},{"key":"20300495_CR60","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0091-3057(94)00267-M","volume":"50","author":"EM Nikulina","year":"1995","unstructured":"Nikulina EM, Skrinskaya JA, Avgustinovich DF, Popova NK. Dopaminergic brain system in the quaking mutant mouse. Pharmacol Biochem Behav 50: 333\u2013337, 1995.","journal-title":"Pharmacol Biochem Behav"},{"key":"20300495_CR61","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1523\/JNEUROSCI.3718-04.2005","volume":"25","author":"DY Hwang","year":"2005","unstructured":"Hwang DY, Fleming SM, Ardayfio P, Moran-Gates T, Kim H, Tarazi FI, Chesselet MF, Kim KS. 3,4-Dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson\u2019s disease. J Neurosci 25: 2132\u20132137, 2005.","journal-title":"J Neurosci"},{"key":"20300495_CR62","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ana.10675","volume":"54","author":"PM Abou-Sleiman","year":"2003","unstructured":"Abou-Sleiman PM, Healy DG, Quinn N, Lees AJ, Wood NW. The role of pathogenic DJ-1 mutations in Parkinson\u2019s disease. Ann Neurol 54: 283\u2013286, 2003.","journal-title":"Ann Neurol"},{"key":"20300495_CR63","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ana.10663","volume":"54","author":"S Hague","year":"2003","unstructured":"Hague S, Rogaeva E, Hernandez D, Gulick C, Singleton A, Hanson M, Johnson J, Weiser R, Gallardo M, Ravina B, Gwinn-Hardy K, Crawley A, St George-Hyslop PH, Lang AE, Heutink P, Bonifati V, Hardy J. Early-onset Parkinson\u2019s disease caused by a compound heterozygous DJ-1 mutation. Ann Neurol 54: 271\u2013274, 2003","journal-title":"Ann Neurol"},{"key":"20300495_CR64","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1212\/01.WNL.0000113022.51739.88","volume":"62","author":"K Hedrich","year":"2004","unstructured":"Hedrich K, Djarmati A, Schafer N, Hering R, Wellenbrock C, Weiss PH, Hilker R, Vieregge P, Ozelius LJ, Heutink P, Bonifati V, Schwinger E, Lang AE, Noth J, Bressman SB, Pramstaller PP, Riess O, Klein C. DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease. Neurology 62: 389\u2013394, 2004.","journal-title":"Neurology"},{"key":"20300495_CR65","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/brain\/awh054","volume":"127","author":"R Bandopadhyay","year":"2004","unstructured":"Bandopadhyay R, Kingsbury AE, Cookson MR, Reid AR, Evans IM, Hope AD, Pittman AM, Lashley T, Canet-Aviles R, Miller DW, McLendon C, Strand C, Leonard AJ, Abou-Sleiman PM, Healy DG, Ariga H, Wood NW, de Silva R, Revesz T, Hardy JA, Lees AJ. The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson\u2019s disease. Brain 127: 420\u2013430, 2004.","journal-title":"Brain"},{"key":"20300495_CR66","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1006\/bbrc.1997.6132","volume":"231","author":"D Nagakubo","year":"1997","unstructured":"Nagakubo D, Taira T, Kitaura H, Ikeda M, Tamai K, Iguchi-Ariga SM, Ariga H. DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem Biophys Res Commun 231: 509\u2013513, 1997.","journal-title":"Biochem Biophys Res Commun"},{"key":"20300495_CR67","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/(SICI)1097-4644(19990301)72:3<435::AID-JCB12>3.0.CO;2-H","volume":"72","author":"Y Hod","year":"1999","unstructured":"Hod Y, Pentyala SN, Whyard TC, El-Maghrabi MR. Identification and characterization of a novel protein that regulates RNA-protein interaction. J Cell Biochem 72: 435\u2013444, 1999.","journal-title":"J Cell Biochem"},{"key":"20300495_CR68","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/10715760100301381","volume":"35","author":"A Mitsumoto","year":"2001","unstructured":"Mitsumoto A, Nakagawa Y. DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin. Free Radic Res 35: 885\u2013893, 2001.","journal-title":"Free Radic Res"},{"key":"20300495_CR69","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/10715760100300831","volume":"35","author":"A Mitsumoto","year":"2001","unstructured":"Mitsumoto A, Nakagawa Y, Takeuchi A, Okawa K, Iwamatsu A, Takanezawa Y. Oxidized forms of peroxiredoxins and DJ-1 on two-dimensional gels increased in response to sublethal levels of paraquat. Free Radic Res 35: 301\u2013310, 2001.","journal-title":"Free Radic Res"},{"key":"20300495_CR70","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1126\/science.1098966","volume":"304","author":"JT Greenamyre","year":"2004","unstructured":"Greenamyre JT, Hastings TG. Biomedicine. Parkinson\u2019s\u2014divergent causes, convergent mechanisms. Science 304: 1120\u20131122, 2004.","journal-title":"Science"},{"key":"20300495_CR71","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.bbrc.2003.11.056","volume":"312","author":"T Yokota","year":"2003","unstructured":"Yokota T, Sugawara K, Ito K, Takahashi R, Ariga H, Mizusawa H. Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. Biochem Biophys Res Commun 312: 1342\u20131348, 2003.","journal-title":"Biochem Biophys Res Commun"},{"key":"20300495_CR72","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1371\/journal.pbio.0020327","volume":"2","author":"C Martinat","year":"2004","unstructured":"Martinat C, Shendelman S, Jonason A, Leete T, Beal MF, Yang L, Floss T, Abeliovich A. Sensitivity to oxidative stress in DJ-1-deficient dopamine neurons: an ES-derived cell model of primary parkinsonism. PLoS Biol 2: e327, 2004.","journal-title":"PLoS Biol"},{"key":"20300495_CR73","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1371\/journal.pbio.0020362","volume":"2","author":"S Shendelman","year":"2004","unstructured":"Shendelman S, Jonason A, Martinat C, Leete T, Abeliovich A. DJ-1 is a redox-dependent molecular chaperone that inhibits \u03b1-synuclein aggregate formation. PLoS Biol 2: e362, 2004.","journal-title":"PLoS Biol"},{"key":"20300495_CR74","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.neuron.2005.01.041","volume":"45","author":"MS Goldberg","year":"2005","unstructured":"Goldberg MS, Pisani A, Haburcak M, Vortherms TA, Kitada T, Costa C, Tong Y, Martella G, Tscherter A, Martins A, Bemardi G, Roth BL, Pothos EN, Calabresi P, Shen J. Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. Neuron 45: 489\u2013496, 2005.","journal-title":"Neuron"},{"key":"20300495_CR75","doi-asserted-by":"crossref","unstructured":"Kim RH, Smith PD, Aleyasin H, Hayley S, Mount MP, Pownall S, Wakeham A, You-Ten AJ, Kalia SK, Home P, Westaway D, Lozano AM, Anisman H, Park DS, Mak TW. Hypersensitivity of DJ-1-deficient mice to l-methyl-4-phenyl-l,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc Natl Acad Sci USA 2005.","DOI":"10.1073\/pnas.0501282102"},{"key":"20300495_CR76","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1210\/me.6.12.2129","volume":"6","author":"SW Law","year":"1992","unstructured":"Law SW, Conneely OM, DeMayo FJ, O\u2019Malley BW. Identification of a new brain-specific transcription factor, NURR1. Mol Endocrinol 6: 2129\u20132135, 1992.","journal-title":"Mol Endocrinol"},{"key":"20300495_CR77","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1006\/bbrc.2000.3204","volume":"274","author":"T Iwawaki","year":"2000","unstructured":"Iwawaki T, Kohno K, Kobayashi K. Identification of a potential nurrl response element that activates the tyrosine hydroxylase gene promoter in cultured cells. Biochem Biophys Res Commun 274: 590\u2013595, 2000.","journal-title":"Biochem Biophys Res Commun"},{"key":"20300495_CR78","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1046\/j.1471-4159.2001.00181.x","volume":"76","author":"P Sacchetti","year":"2001","unstructured":"Sacchetti P, Mitchell TR, Granneman JG, Bannon MJ. Nurrl enhances transcription of the human dopamine transporter gene through a novel mechanism. J Neurochem 76: 1565\u20131572, 2001.","journal-title":"J Neurochem"},{"key":"20300495_CR79","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ng1066","volume":"33","author":"WD Le","year":"2003","unstructured":"Le WD, Xu P, Jankovic J, Jiang H, Appel SH, Smith RG, Vassilatis DK. Mutations in NR4A2 associated with familial Parkinson disease. Nat Genet 33: 85\u201389, 2003.","journal-title":"Nat Genet"},{"key":"20300495_CR80","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.276.5310.248","volume":"276","author":"RH Zetterstrom","year":"1997","unstructured":"Zetterstrom RH, Solomin L, Jansson L, Hoffer BJ, Olson L, Perlmann T. Dopamine neuron agenesis in Nurr1-deficient mice. Science 276: 248\u2013250, 1997.","journal-title":"Science"},{"key":"20300495_CR81","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1046\/j.1471-4159.1999.02218.x","volume":"73","author":"W Le","year":"1999","unstructured":"Le W, Conneely OM, He Y, Jankovic J, Appel SH. Reduced Nurr1 expression increases the vulnerability of mesencephalic dopamine neurons to MPTP-induced injury. J Neurochem 73: 2218\u20132221, 1999.","journal-title":"J Neurochem"},{"key":"20300495_CR82","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.expneurol.2004.08.035","volume":"191","author":"C Jiang","year":"2005","unstructured":"Jiang C, Wan X, He Y, Pan T, Jankovic J, Le W. Age-dependent dopaminergic dysfunction in Nurr1 knockout mice. Exp Neurol 191: 154\u2013162, 2005.","journal-title":"Exp Neurol"},{"key":"20300495_CR83","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.0230529100","volume":"100","author":"I Nunes","year":"2003","unstructured":"Nunes I, Tovmasian LT, Silva RM, Burke RE, Goff SP. Pitx3 is required for development of substantia nigra dopaminergic neurons. Proc Natl Acad Sci USA 100: 4245\u20134250, 2003.","journal-title":"Proc Natl Acad Sci USA"},{"key":"20300495_CR84","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0169-328X(03)00162-1","volume":"114","author":"DY Hwang","year":"2003","unstructured":"Hwang DY, Ardayfio P, Kang UJ, Semina EV, Kim KS. Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice. Brain Res Mol Brain Res 114: 123\u2013131, 2003.","journal-title":"Brain Res Mol Brain Res"},{"key":"20300495_CR85","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1093\/hmg\/9.11.1575","volume":"9","author":"EV Semina","year":"2000","unstructured":"Semina EV, Murray JC, Reiter R, Hrstka RF, Graw J. Deletion in the promoter region and altered expression of Pitx3 homeobox gene in aphakia mice. Hum Mol Genet 9: 1575\u20131585, 2000.","journal-title":"Hum Mol Genet"}],"container-title":["NeuroRX"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1602\/neurorx.2.3.495","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T19:18:46Z","timestamp":1706296726000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1602\/neurorx.2.3.495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["20300495"],"URL":"https:\/\/doi.org\/10.1602\/neurorx.2.3.495","relation":{},"ISSN":["1545-5343"],"issn-type":[{"value":"1545-5343","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}